Biohaven Ltd. (BHVN)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Biohaven Ltd. (BHVN)
Company Performance

Current Price

as of Oct 29, 2024

$50.95

P/E Ratio

N/A

Market Cap

$5.09B

Description

Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.

Metrics

Overview

  • HQNew Haven, CT
  • SectorHealth Technology
  • IndustryPharmaceuticals: Major
  • TickerBHVN
  • Price$50.95-1.55%

Trading Information

  • Market Cap$5.09B
  • Float87.09%
  • Average Daily Volume (1m)974,178
  • Average Daily Volume (3m)975,136
  • EPS-$9.16

Company

  • RevenueN/A
  • Rev Growth (1yr)N/A
  • Net Income-$319.77M
  • Gross MarginN/A
  • EBITDA MarginN/A
  • EBITDA-$332.79M
  • EV$2.64B
  • EV/RevenueN/A
  • P/EN/A
  • P/SN/A
  • P/B12.26
Documents